Effect of Some Drugs on Rheumatoid Arithritis Activity

Phase 3

Recruiting

• Conditions: Rheumatoid Arthritis
• Interventions: Drug: Rupatadine; Drug: Montelukast

• Registration Number: NCT03770923
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Detailed Description

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

Study Timeline

• Study Start: 2018-10-01
• Status Verified: 2018-12
• Study First Submitted: 2018-12-07
• Study First Submitted QC: 2018-12-07
• Last Update Submitted: 2018-12-07
• Study First Posted: 2018-12-10
• Last Update Posted: 2018-12-10
• Primary Completion: 2026-10
• Study Completion: 2027-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Rheumatoid arthritis

Exclusion Criteria

• liver or renal disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Rupatadine	Rupatadine	Rupatadine 10 mg once daily.
Montelukast	Montelukast	Montelukast 10 mg daily

Primary Outcome Measures

Name	Time	Method
se level of IL-17	6 months	change in level of IL-17

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Tanta, Egypt